SOPH (Sophia Genetics) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


SOPH Sophia Genetics SA SOPH
72 GF Score
Price $5.87
GF Value $5.03
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sophia Genetics Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Sophia Genetics's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SOPH vs SLP, TBRG, CARL: Margin of Safety % (DCF Earnings Based) Comparison

For the Health Information Services subindustry, Sophia Genetics's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sophia Genetics Margin of Safety % (DCF Earnings Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sophia Genetics's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Sophia Genetics's Margin of Safety % (DCF Earnings Based) falls into.


SOPH
72GF Score
Sophia Genetics SA SOPH
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sophia Genetics (SOPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued. The current stock price of $5.87 is trading 16.6% above its estimated GF Value™ of $5.03. GuruFocus considers Sophia Genetics to be Modestly Overvalued.

Key valuation signals for SOPH:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $5.03 vs. price of $5.87 (16.6% above fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the SOPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sophia Genetics Business Description

Other Exchanges 90B:Germany
Address La Piece 12, Rolle, CHE, CH-1180
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
72GF Score

Get the complete analysis for SOPH

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.87
Price
$5.03
GF Value